Immunological basis in the pathogenesis and treatment of bladder cancer
- 13 November 2014
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Clinical Immunology
- Vol. 11 (2) , 265-279
Abstract
(2015). Immunological basis in the pathogenesis and treatment of bladder cancer. Expert Review of Clinical Immunology: Vol. 11, No. 2, pp. 265-279.Keywords
This publication has 104 references indexed in Scilit:
- IL-6 Expression Regulates Tumorigenicity and Correlates with Prognosis in Bladder CancerPLOS ONE, 2013
- Stat3 Activation in Urothelial Stem Cells Leads to Direct Progression to Invasive Bladder CancerCancer Research, 2012
- Attenuation of human neutrophil migration and function by uropathogenic bacteriaMicrobes and Infection, 2011
- Macrophage Diversity Enhances Tumor Progression and MetastasisCell, 2010
- Immunity, Inflammation, and CancerCell, 2010
- Mycobacterium bovis Bacillus Calmette‐Guérin‐Induced Macrophage Cytotoxicity against Bladder Cancer CellsJournal of Immunology Research, 2010
- Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cellsProceedings of the National Academy of Sciences, 2009
- Tumor Microenvironment of Metastasis in Human Breast Carcinoma: A Potential Prognostic Marker Linked to Hematogenous DisseminationClinical Cancer Research, 2009
- Arginase I–Producing Myeloid-Derived Suppressor Cells in Renal Cell Carcinoma Are a Subpopulation of Activated GranulocytesCancer Research, 2009
- Role of neutrophils in BCG immunotherapy for bladder cancerUrologic Oncology: Seminars and Original Investigations, 2008